188 related articles for article (PubMed ID: 25521775)
1. Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin.
Tyagi C; Gupta A; Goyal S; Dhanjal J; Grover A
BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S3. PubMed ID: 25521775
[TBL] [Abstract][Full Text] [Related]
2. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
3. QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents.
Habibpour E; Ahmadi S
Curr Comput Aided Drug Des; 2017; 13(2):143-159. PubMed ID: 28120704
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into the design of indole derivatives as tubulin polymerization inhibitors.
Li Y; Yang J; Niu L; Hu D; Li H; Chen L; Yu Y; Chen Q
FEBS Lett; 2020 Jan; 594(1):199-204. PubMed ID: 31369682
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL
Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164
[TBL] [Abstract][Full Text] [Related]
6. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
Coluccia A; Sabbadin D; Brancale A
Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
[TBL] [Abstract][Full Text] [Related]
7. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site.
Li L; Jiang S; Li X; Liu Y; Su J; Chen J
Eur J Med Chem; 2018 May; 151():482-494. PubMed ID: 29649743
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
10. Fragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia.
Sinha S; Tyagi C; Goyal S; Jamal S; Somvanshi P; Grover A
J Biomol Struct Dyn; 2016 Oct; 34(10):2281-95. PubMed ID: 26510381
[TBL] [Abstract][Full Text] [Related]
11. Discovery and molecular modeling of novel 1-indolyl acetate--5-nitroimidazole targeting tubulin polymerization as antiproliferative agents.
Duan YT; Sang YL; Makawana JA; Teraiya SB; Yao YF; Tang DJ; Tao XX; Zhu HL
Eur J Med Chem; 2014 Oct; 85():341-51. PubMed ID: 25105922
[TBL] [Abstract][Full Text] [Related]
12. A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin.
Xian J; Bu F; Wang Y; Long F; Zhang Z; Wu C; Tao Y; Wang T; Wang G
Molecules; 2021 Feb; 26(4):. PubMed ID: 33579052
[TBL] [Abstract][Full Text] [Related]
13. NMK-TD-100, a novel microtubule modulating agent, blocks mitosis and induces apoptosis in HeLa cells by binding to tubulin.
Bhattacharya S; Kumar NM; Ganguli A; Tantak MP; Kumar D; Chakrabarti G
PLoS One; 2013; 8(10):e76286. PubMed ID: 24116100
[TBL] [Abstract][Full Text] [Related]
14. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel class of tubulin inhibitors with promising anticancer activities.
Xi J; Zhu X; Feng Y; Huang N; Luo G; Mao Y; Han X; Tian W; Wang G; Han X; Luo R; Huang Z; An J
Mol Cancer Res; 2013 Aug; 11(8):856-64. PubMed ID: 23666368
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents.
Wang SF; Yin Y; Zhang YL; Mi SW; Zhao MY; Lv PC; Wang BZ; Zhu HL
Eur J Med Chem; 2015 Mar; 93():291-9. PubMed ID: 25703297
[TBL] [Abstract][Full Text] [Related]
17. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
18. Combined Molecular Docking, 3D-QSAR, and Pharmacophore Model: Design of Novel Tubulin Polymerization Inhibitors by Binding to Colchicine-binding Site.
Li DD; Qin YJ; Zhang X; Yin Y; Zhu HL; Zhao LG
Chem Biol Drug Des; 2015 Oct; 86(4):731-45. PubMed ID: 25711282
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
Yao Y; Huang T; Wang Y; Wang L; Feng S; Cheng W; Yang L; Duan Y
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):652-665. PubMed ID: 35109719
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors.
Baytas SN; Inceler N; Yilmaz A; Olgac A; Menevse S; Banoglu E; Hamel E; Bortolozzi R; Viola G
Bioorg Med Chem; 2014 Jun; 22(12):3096-104. PubMed ID: 24816066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
